Calmpose

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calmpose

Calmpose is the trade name for a medication used to provide immediate calming and muscle-relaxing effects. It is a prescription-only (Rx) drug that requires close medical supervision.

Property Description
Active Ingredient Diazepam
Pharmacological Class Benzodiazepine Derivative
Common Forms Tablet, Injection, Rectal gel
General Purpose Anxiolytic and Muscle Relaxant
Origin Synthetic (Chemically manufactured)

What Type of Medicine is Calmpose?

Calmpose is the brand name for the synthetic medication whose active ingredient is diazepam. It is formally classified as a benzodiazepine and is clinically recognized for its ability to stabilize the central nervous system. The brand itself, long associated with its original marketer and currently with Sun Pharma, is historically known as one of the first major tranquilizers widely used in the Indian pharmaceutical market.

As a Schedule IV controlled substance, Calmpose is distinguished from non-prescription alternatives by its potent, fast-acting sedative effects, reinforcing its status as a drug for acute, short-term management under a physician's guidance.


Composition and Available Forms

The therapeutic effect of Calmpose comes from the single active ingredient, diazepam, which is chemically manufactured. This focused composition allows it to target the nervous system effectively.

Calmpose is primarily available for oral administration as a tablet. However, the availability of a sterile injection formulation is a key differentiating factor, positioning Calmpose for use in hospital and emergency settings where immediate onset of action is required, such as managing prolonged seizure activity. This versatility is a characteristic of its pharmacological profile.


What is the General Therapeutic Purpose?

The overall therapeutic purpose of Calmpose is to act as an anxiolytic and a skeletal muscle relaxant. It achieves this by boosting the effect of GABA (gamma-aminobutyric acid), the brain's natural inhibitory chemical, thereby reducing overactivity of the nerve cells.

This dual action provides relief from both the mental distress of anxiety and associated physical symptoms like muscle tension. Its clinical utility for providing relief from both nervous and muscular overactivity is recognized through its long-standing use in clinical practice.

Regulatory References

  1. StatPearls Link

What side effects are possible with Calmpose?

Possible Side Effects and Safety Information

Calmpose (diazepam) is associated with an official safety profile categorized by regulatory authorities to clarify known risks, frequency, and severity. This information is based strictly on documents such as the FDA Prescribing Information and the European Summary of Product Characteristics (SmPC).

Classification Examples of Officially Documented Adverse Reactions
Common Effects Drowsiness, fatigue, unsteadiness (ataxia), muscle weakness. These CNS-related effects are typically dose-dependent and may appear most frequently at the start of treatment (EMA SmPC).
Uncommon Effects Confusion, dizziness, slurred speech (dysarthria), depression, and visual disturbances. Gastrointestinal reactions like nausea and constipation may also occur.
Serious Risks Severe respiratory depression (especially when used with opioids, which carries a Boxed Warning risk), the potential for physical dependence and withdrawal syndrome upon abrupt discontinuation, and rare occurrences of blood dyscrasias or jaundice (FDA Label).

System-Organ Class (SOC) Groupings

The adverse effects are generally grouped by the physiological system affected, including Nervous System Disorders (e.g., sedation, tremor), Psychiatric Disorders (e.g., paradoxical reactions like agitation, hostility), and effects on the Hepatobiliary System (e.g., jaundice).

Population-Specific and Use-Related Safety Constraints

  • Older Adults: This population is officially noted to be more sensitive to the depressant effects, increasing the risk of oversedation and coordination issues.
  • Contraindications: The medicine is contraindicated (should not be used) in patients with severe respiratory insufficiency, severe hepatic insufficiency, myasthenia gravis, and sleep apnoea syndrome (FDA/SmPC).
  • Dependence: The risk of physical and psychological dependence is documented to increase with both the dose and the duration of treatment.

Connection to the Official Safety Profile

The regulatory safety information establishes that while the most common adverse reactions are related to CNS depression, the primary clinically significant risks involve severe respiratory depression and the dangers of dependence and withdrawal. By defining both common and serious outcomes and listing contraindications, the official label outlines precise safety boundaries and high-risk scenarios for the medicine's use.

Overdose and Emergency Response

The official regulatory documents define a Calmpose (Diazepam) overdose primarily as a state of dose-dependent central nervous system (CNS) depression. Documented overdose presentations range from mild signs of confusion, somnolence, and impaired motor function (ataxia and hypotonia) to more severe clinical effects.

The most serious outcomes described in regulatory labeling involve the escalation of CNS depression, leading to profound sedation, coma, respiratory depression, and potentially death. The risk of these life-threatening events is significantly increased with co-ingestion of other CNS depressants, such as alcohol. The injectable form also carries a specific, high-dose risk of Propylene Glycol Toxicity, leading to complications like metabolic acidosis.

In the event of any suspected overdose, official instructions mandate that patients or caregivers seek immediate medical attention and contact emergency services or a poison control center right away. Urgent medical help is required for any persistent or worsening signs of intoxication.

Regulatory guidance states that overdose management is primarily symptomatic and supportive, emphasizing airway maintenance and continuous monitoring of vital signs (ECG, blood pressure). While a specific benzodiazepine antagonist, Flumazenil, is available, its routine use for reversal is cautioned against by regulators due to the risk of precipitating seizures. Furthermore, regulatory documents specify that elderly and very ill patients face an increased risk of severe cardiorespiratory complications, including apnea and cardiac arrest.

Therapeutic Uses of Calmpose

Calmpose (diazepam) is primarily used for the short-term symptomatic relief of conditions marked by symptoms related to heightened physiological activity, tension, and functional strain.

The medicine is relevant for easing symptoms in conditions including anxiety disorders, acute alcohol withdrawal, certain types of muscle spasms, and as an adjunct for specific seizure disorders.

When symptoms become more noticeable, this medicine is commonly used for supportive relief to help address symptomatic discomfort:

to help with symptoms that are causing distress.

Quick Fact: Supports Management of Heightened Tension

Calmpose provides support that helps ease the overall symptom burden associated with periods of increased physiological stress, assisting patients in coping more steadily with difficult episodes and maintaining functional stability.

The core benefit is to help address symptom clusters that may become intense or disruptive, offering temporary assistance when short-term symptomatic support is appropriate across various clinical settings.

Eligibility and Restrictions for Use

The official regulatory documents define the strict population eligibility for Calmpose (diazepam), establishing groups who are absolutely prohibited from use and populations who require heightened caution and special consideration. Eligibility is determined by pre-existing conditions, age, and physiological status.

Absolute Contraindications (Prohibited Use) Restricted or Conditional Use
Known hypersensitivity to diazepam or benzodiazepines Older adults (requires lower initial dose)
Severe respiratory insufficiency / Sleep apnoea syndrome Patients with mild/moderate hepatic or renal impairment
Severe hepatic insufficiency (liver failure) History of alcohol or drug abuse (requires extreme caution)
Myasthenia gravis or Acute narrow-angle glaucoma Not recommended as sole therapy for severe depression

Pediatric patients under 6 months of age are generally considered a contraindicated population due to the lack of sufficient clinical experience establishing safety and efficacy. Use is established for adults and for children aged 6 months and older for specific, labeled purposes. Additionally, the medicine is not recommended for use during pregnancy, and its use during breastfeeding is generally not advised due to the risk of accumulation in the nursing infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Calmpose (diazepam) has significant drug-drug and drug-substance interactions, primarily due to its effects as a central nervous system (CNS) depressant and how it is metabolized by the body.

Critical CNS Depressant Interactions

Opioids: The most critical interaction is with opioid medicines (such as morphine, oxycodone, codeine, or tramadol). Concomitant use with Calmpose is strongly discouraged as it may result in profound sedation, respiratory depression, coma, and death. Regulatory bodies mandate that this combination be reserved only for patients where alternative options are inadequate, utilizing the lowest possible dosages and durations, with careful monitoring.

Alcohol: Co-ingestion of alcohol (ethanol) is prohibited. Alcohol dramatically increases the sedative effects of Calmpose, raising the risk of severe drowsiness, dizziness, and life-threatening respiratory depression.

Other CNS Depressants: Caution is mandatory with other medicines that cause sleepiness, including antipsychotics, antidepressants, sedating antihistamines, anxiolytics, hypnotics, and muscle relaxants, as these combinations potentiate the effects of Calmpose, increasing the risk of adverse events.

Metabolic Interactions

Certain medicines can affect how Calmpose is broken down by the liver, altering its concentration in the blood:

  • Enzyme Inhibitors (e.g., specific antifungals like fluconazole or some stomach acid reducers like omeprazole) can increase Calmpose blood levels, raising the risk of side effects.
  • Enzyme Inducers (e.g., rifampicin, theophylline) can decrease Calmpose blood levels, potentially reducing its effectiveness.

Mechanism of Action

Calmpose (Diazepam) functions as a positive allosteric modulator of the GABAA (gamma-aminobutyric acid type A) receptor complex. This complex is a ligand-gated ion channel located in the neuronal membranes throughout the central nervous system (CNS).

The interaction involves Diazepam binding to a specific site on the receptor interface, distinct from the binding site of the endogenous neurotransmitter, GABA. This binding action enhances the affinity of the receptor for GABA. The pathway modulation results in a greater frequency of chloride ion channel opening when GABA is present. This mechanistic cascade increases the influx of negatively charged chloride ions into the neuron. This change in membrane potential leads to hyperpolarization of the neuron, making it less excitable and less responsive to subsequent excitatory signals. The system-level physiological consequence of this widespread neuronal inhibition is a general reduction in overall brain activity in the CNS.

Dosage and Administration Information

Calmpose, which contains the active ingredient diazepam, is administered in accordance with clinical protocols that define its use in medical settings. The medicine is available for oral administration as a tablet for scheduled, non-acute use, and as a sterile solution for injection (IV/IM) or a rectal gel for acute, urgent scenarios where immediate action is required.


Administration Protocol

The standard adult oral dosing for conditions like anxiety relief is typically 2 mg to 10 mg, taken in divided doses 2 to 4 times daily. For acute events such as prolonged seizures, the intravenous dose is 5 mg to 10 mg, and the total dose per course of treatment typically does not exceed 30 mg.

Duration and Special Conditions

Treatment duration is generally intended to be the shortest possible, often not exceeding 2 to 4 weeks for anxiety symptoms, which includes the time necessary for gradual dose reduction (tapering).

Specific procedures are followed for the injectable formulation: the solution must not be mixed or diluted with other drugs, and intravenous injection is administered slowly, at a rate of no more than 5 mg per minute.

Population Adjustments

Initial dose reductions are common for certain patient groups, most notably older adults and individuals with hepatic impairment. The starting dose for older adults, for instance, is often adjusted (e.g., 2 mg to 2.5 mg, 1 to 2 times daily) to minimize the risk of cumulative effects.

Recent Clinical Evidence

Research evidence / Overview of Studies for Calmpose

Evidence for Short-Term Relief of Anxiety Symptoms

The research base exploring Calmpose (diazepam) includes short-term randomized controlled trials (RCTs) and systematic reviews. Studies examined how symptoms evolved over defined, limited time intervals, often a few weeks, by monitoring changes in severity using standardized clinical scales. Some meta-analyses reported that groups receiving this medicine showed different rates of reported symptom change compared to groups receiving a placebo.

However, a key limitation is the follow-up duration of these studies. Most primary trials exploring short-term symptom relief did not extend beyond 4 to 8 weeks. Consequently, long-term effects are not fully established, and limited information is available for outcomes related to continuous or chronic use.


Evidence for Acute Alcohol Withdrawal and Seizure Management

This medicine was evaluated in research contexts involving fluctuating or unstable symptoms in specific acute settings.

For acute alcohol withdrawal, large-scale trials and meta-analyses were conducted to study the use of benzodiazepines, including diazepam, during periods of increased symptom activity. Research examined outcomes related to systemic imbalance, such as successful symptom stabilization, and the prevention of severe episodic changes. Findings describe patterns observed in controlled trials that examined this class of medicine in the management of this acute scenario.

Research Focus on Prevention of Acute Complications

In the context of acute repetitive seizures (seizure clusters), studies explored different formulations, such as injections or gels, focusing on episodes where seizures become more noticeable. Research monitored outcomes linked to episodic or acute changes, specifically measuring the time to seizure cessation and the proportion of events terminated successfully. The rapid-acting forms have been studied in research, and studies are ongoing to explore alternative administration methods.


Identified Research Gaps and Uncertainty

Despite decades of use, the research record highlights areas where further study would provide more insight:

  • Long-term effects are not fully established, especially regarding the durability of effectiveness and potential changes over periods exceeding a few months.
  • Comparative evidence is sometimes lacking or heterogeneous when comparing Calmpose directly against newer, non-benzodiazepine medicines across all approved indications.
  • Studies explored short-term changes; however, research focusing on patient-reported outcomes describing long-term quality of life or sustained daily functioning in non-acute settings remains limited.

Key Studies & References Diazepam (StatPearls - NCBI Bookshelf Monograph)

Frequently Asked Questions (FAQ)

Common questions about Calmpose (FAQ)


Q: How quickly does Calmpose typically begin to work?

A: According to the official product information, when taking the oral tablet, the time it takes to reach the highest concentration in the blood is typically between 1 and 1.5 hours. However, this onset time can sometimes range from 15 minutes up to 2.5 hours. For the injection forms, which are used in urgent scenarios, the effect is described as immediate.


Q: How long does the effect of Calmpose usually last in the body?

A: Calmpose (diazepam) has a prolonged elimination phase, with the half-life of the active ingredient lasting up to 48 hours. Furthermore, the main chemical breakdown product, which is also active, can remain in the body for an even longer period, with a half-life of up to 100 hours. This means the substance and its effects are present in the body for an extended time.


Q: Is it safe to drink coffee or caffeine while using Calmpose?

A: Official information indicates that substances like caffeine may decrease the therapeutic effect of Calmpose. The medicine’s regulatory instructions include caution regarding substances that could alter its intended effects.


Q: Is Calmpose ever prescribed for short-term use only?

A: Regulatory documents state that treatment duration should generally be the shortest possible time to minimize risks. For conditions like anxiety symptoms, official guidelines suggest a duration often not exceeding two to four weeks, which includes the necessary time for gradually reducing the dose.


Q: Is Calmpose used for sleep problems?

A: The primary approved uses for Calmpose do not list chronic insomnia (ongoing difficulty sleeping) as a main indication. However, due to its main purpose as an anti-anxiety and muscle-relaxing agent, the secondary effect of calming the central nervous system may overlap with sleep difficulties associated with those conditions.


Q: Can Calmpose be taken on an empty stomach?

A: Regulatory documents indicate that taking the oral tablet with food can delay the rate at which the medicine reaches its peak level in the blood. The documentation notes that taking the tablet with food may delay the rate at which the medicine reaches its peak level in the blood and may reduce the total amount absorbed.


Q: Do studies support the uses listed for Calmpose?

A: The research base includes short-term randomized controlled trials and comprehensive reviews examining its effectiveness for anxiety relief, acute alcohol withdrawal, and seizure management. However, official documents consistently note that research focusing on the effects of long-term or continuous use is limited.


Q: Does Calmpose lose its effectiveness over time?

A: Official information discusses the potential for tolerance with continued use. Tolerance is when the body adapts to the medicine, possibly reducing its original effectiveness over time. This risk is officially noted to increase with both the dose and the duration of the treatment period.


Q: Do children or teenagers ever use Calmpose for approved conditions?

A: Yes, regulatory documents establish that Calmpose is used in children aged six months and older for specific, labeled purposes, such as managing muscle spasms or as an additional treatment for seizure activity. It is generally not recommended for infants under six months of age.


Q: Is Calmpose considered a strong medicine?

A: The medicine is classified as a Schedule IV controlled substance in the United States due to its potential for misuse and dependence. Official descriptions also refer to it as having potent, fast-acting sedative effects, which reinforces why close medical supervision is required for its use.


Q: What is the difference between Calmpose and a generic version?

A: Calmpose is the trade name for the active ingredient, diazepam. The generic version contains the identical active ingredient in the same strength. Regulatory standards require that generic medicines be bioequivalent, meaning they must work in the body in the same way as the original branded product.


Q: Can Calmpose affect my ability to drive or operate machinery?

A: Official safety warnings caution that because Calmpose can slow down the central nervous system, it may impair judgment, thinking, and motor skills. The official warnings state that performing such tasks should be deferred until the user is certain of the medicine's effects on them.


Q: Are there specific foods or drinks to avoid when taking Calmpose?

A: Official warnings specifically cite grapefruit and grapefruit juice as substances to be avoided. These can interfere with the way the liver breaks down the medicine, which may increase the amount of the drug in the body and raise the risk of experiencing side effects.


Q: Is it normal to feel a bit light-headed after taking Calmpose?

A: The official safety profile lists unsteadiness (ataxia), dizziness, and fatigue as common side effects, which may be perceived as feeling light-headed by some individuals. These effects are generally dependent on the dose and may be more noticeable at the beginning of treatment.


Q: Is there a maximum time frame for how long Calmpose is usually prescribed?

A: Official guidelines emphasize that the duration of treatment should be as short as possible. For anxiety, documents indicate that treatment should not typically exceed 8 to 12 weeks, including the necessary time for the dose to be gradually reduced. This guideline is in place due to the risk of dependence.


Q: Can Calmpose cause changes in mood or behavior?

A: Yes, the official safety profile includes reports of 'paradoxical reactions,' which are changes in mood or behavior that are the opposite of the medicine's intended calming effect. These changes may include feelings of agitation, hostility, or aggressiveness.


Q: Is there a certain time of day that is best for taking Calmpose?

A: The official dosing instructions indicate that the medicine is typically taken in divided doses, from two to four times a day. This suggests that the timing is intended to be spread throughout the day to match the specific condition and symptoms being treated.


Q: Can Calmpose make existing mental health conditions worse?

A: Official warnings state that the medicine is not recommended as the sole treatment for severe depression. There are documented risks concerning the worsening of certain psychiatric symptoms, including potential risks for suicidal thoughts or behaviors.


Q: Is Calmpose generally considered safe for healthy adults?

A: Official documentation outlines specific reasons why the medicine should strictly not be used, known as contraindications, such as severe respiratory or liver problems, myasthenia gravis, and sleep apnoea syndrome. The presence of these contraindications defines populations for whom the medicine should strictly not be used.


Q: Are there any specific safety rules mentioned by regulatory bodies for Calmpose?

A: Yes, regulatory bodies issue specific safety rules, notably a Boxed Warning that details the serious risks associated with taking the medicine concurrently with opioid medications. This combination can lead to severe sedation, life-threatening respiratory depression, coma, and death.


Q: Are there known cases where Calmpose is strictly not recommended?

A: Yes, regulatory documents list absolute contraindications, meaning the medicine is strictly not recommended. These include known hypersensitivity (allergy) to the drug, severe liver or respiratory insufficiency, myasthenia gravis, and sleep apnoea syndrome.


Q: Is it normal to feel more tired than usual in the first few days of taking Calmpose?

A: Yes, official safety information states that common side effects related to the central nervous system, such as drowsiness and fatigue, may be most noticeable at the start of treatment. These effects are typically linked to the dose being used.


Q: Do many people experience withdrawal effects when stopping Calmpose?

A: Official warnings highlight that physical dependence and subsequent withdrawal syndrome are known risks, particularly after longer periods of treatment. Official guidelines describe that a slow, gradual dose reduction is the principle used to manage and minimize the potential for these effects.


Q: Does the strength of Calmpose vary between different manufacturers?

A: Regulatory standards require that the strength of the active ingredient, diazepam, must be the same whether it is the brand name product or a generic version. The exact amount of active medicine (e.g., 2mg, 5mg, or 10mg) is consistent across all approved manufacturers.


Q: Can Calmpose affect blood pressure?

A: While not always listed as a common side effect in official documents, the medicine's depressant effect on the central nervous system can impact the cardiovascular system. Rare instances of low blood pressure (hypotension) have been reported in the safety profile.


Q: Is Calmpose approved in many countries?

A: The active ingredient, diazepam, is regulated and reviewed by major bodies such as the FDA (U.S.) and the EMA (Europe). It is also listed on the World Health Organization's List of Essential Medicines, which indicates its international recognition and importance in global healthcare.


Q: Why is Calmpose sometimes described as a 'tranquilizer'?

A: Calmpose belongs to the pharmacological class known as benzodiazepine derivatives. Historically, this class of medications was often referred to informally as 'minor tranquilizers' due to their ability to produce a calming and sedative effect on the central nervous system.

How should Calmpose be stored and disposed of?

Storage & Disposal Scope

Scope Item Official Regulatory Requirement
Labeled storage temperature requirements Store at Controlled Room Temperature (CRT): 20 to 25 C (68 to 77 F).
Light/moisture protection requirements Must be protected from light. Keep container tightly closed.
Packaging-related storage rules Store in a tightly closed, light-resistant container (for Oral Solution).
Disposal instructions (as documented in government sources) Unused product must be discarded using the regulatory-mandated procedure: mix with an unappealing substance and place in sealed bag in household trash.
Child-protection storage requirements Must be kept in a safe place and out of the reach of children.

Storage/Disposal Classifications

Classification Item Regulatory Classification/Description
Storage condition type Controlled Room Temperature / Protect from Light
Regulatory basis U.S. FDA / NIH DailyMed

Resulting Storage & Disposal Structure

Official labeling mandates that Calmpose must be stored within the defined Controlled Room Temperature range and protected from light, typically by keeping it in a tightly closed, light-resistant container. As a Schedule IV controlled substance, secure storage is strictly required to keep the medicine out of the reach of children and prevent misuse. Unused or expired quantities must follow the specific disposal procedure outlined by the FDA: mixing the product with an unappealing material and discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calmpose found in:

A-Z Index: